FDA OKs Tysabri to Fight Crohn’s Disease
Tysabri, a treatment for multiple sclerosis made by Biogen Idec Inc. and Elan Corp., received regulatory approval on Monday for use among patients with a severe intestinal disorder.The Food and Drug Administration approved Tysabri for use in patients with moderate to severe Crohn’s disease who don’t respond to more conventional drugs, such as Abbott Laboratories’ Humira.The approval represents a comeback for Tysabri, which was temporarily pulled from the market in 2005 after three patients using the drug developed a rare nervous system disorder called multifocal leukoencephalopathy, or PML. Read more
Cancer study finds adolescents don’t get same access to latest treatments as younger patients
“Research has shown that patients who are enrolled in clinical trials offering the most advanced cancer treatments do better than patients who receive conventional treatment” The overall survival rate from cancer now is lower in older adolescents and young adults with cancer than in younger children, in part because of a lack of access to clinical trials nationally for the older age … via Physics Blog
Gold Digging For health .Price - 37.95
My younger sister was a pest, as most siblings are. She would […]
In-Sink-Erator 3/4 HP 60 Hz Stainless Batch Feed Food Waste Disposer #17
In-Sink-Erator 3/4 HP 60 Hz Stainless Batch Feed food Waste Disposer #17 InSinkErator 17 Stainless Steel Stainless steel. Household Disposer 17 - Slate - These incentives coupled with inertia from having done studies the same way for so long are a recipe for inefficiency. There are more Phase 2 trials in cancer than in […]
3 Responses to “FDA OKs Tysabri to Fight Crohn’s Disease”
Leave a Reply
You must be logged in to post a comment.
January 17th, 2008 at 2:24 pm
[…] FDA OKs Tysabri to Fight Crohn s Disease Tysabri, a treatment for multiple sclerosis made by Biogen Idec Inc. and Elan Corp., received regulatory approval on Monday for use among patients with a severe intestinal disorder.The Food and Drug Administration approved Tysabri for use in patients with moderate to severe Crohn’s disease who don’t respond to more conventional drugs, such as Abbott […] […]
January 19th, 2008 at 7:02 pm
[…] FDA OKs Tysabri to Fight Crohn s Disease Tysabri, a treatment for multiple sclerosis made by Biogen Idec Inc. and Elan Corp., received regulatory approval on Monday for use among patients with a severe intestinal disorder.The Food and Drug Administration approved Tysabri for use in patients with moderate to severe Crohn’s disease who don’t respond to more conventional drugs, such as Abbott […] […]
January 20th, 2008 at 10:25 am
[…] FDA OKs Tysabri to Fight Crohn s Disease Tysabri, a treatment for multiple sclerosis made by Biogen Idec Inc. and Elan Corp., received regulatory approval on Monday for use among patients with a severe intestinal disorder.The Food and Drug Administration approved Tysabri for use in patients with moderate to severe Crohn’s disease who don’t respond to more conventional drugs, such as Abbott […] […]